Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Noninvasive Cancer Diagnostics and Technologies Market - Global Share, Industry Overview, Analysis, Growth, Trends Opportunities and Forecast 2012 - 2020
Upcoming: Nov-2014    |    Formats: PDF & Excel    |    Code: ME 1470    |   
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology

Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. Commercialization of non-invasive cancer diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic market. The Ovarian Cancer National Alliance regulations for monitoring non-invasive diagnostics are issued by FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA).

The global non-invasive market has a huge potential in developing countries; however, cost of diagnosis is creating hurdles to tap this market. Hence, to overcome this problem, the diagnostic market has to be analyzed by the developing countries such as China, Japan, and India. This report provides key market drivers that are driving the market with impact analysis. The report gives intelligence about key regulatory guidelines issued by respective governments.

Key companies included in report are Precision Therapeutics, A&G Pharmaceutical, Affymetrix Inc., AVIVA Biosciences Corporation, BIOVIEW Inc., Laboratory Corporation of America Holdings (LabCorp), , Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation, Gen-Probe Incorporated, 

KEY BENEFITS

  • Key developmental strategies adopted by top market players engaged in this business so that companies involved in development non-invasive cancer diagnostic device can get competitive intelligence of their competitors
  • Market estimation for therapeutics techniques and geographic segment is derived from current market scenario and expected market trends
  • Market attractiveness analysis has been included for various product segments, therapeutics, techniques and geographic regions with detailed analysis of factors responsible for rapid growth of the market segments
  • In depth analysis of key market drivers, restraints and opportunities of non-invasive cancer diagnostic market with impact analysis
  • Value chain analysis, Porter’s five force model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report so that the decision makers can receive clear picture of cancer diagnosis market

KEY MARKET SEGMENTS

GLOBAL MARKET,  BY THERAPEUTICS

       • Solid tumors
       • Blood cancer
       • Lung Cancer
       • Breast Cancer
       • Others

GLOBAL MARKET,  BY TECHNIQUES
       • Clinical Chemistry
       • Immunochemistry/Immunoassay
       • Molecular Diagnostics
       • Other Clinical Instruments

GLOBAL MARKET,  BY GEOGRAPHY
       • North America
       • Europe
       • Asia-Pacific
       • RoW

KEY AUDIENCES
   • Medical devices manufacturing companies
   • Pharmaceutical companies
   • Government and Private Research Institutes
   • Academic Institutes

Please fill in the form below to get a TOC

* Marked Fields are Mandatory






image



Can't read the image? click here to refresh
     
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
SIMILAR MARKET STUDIES

Published Reports

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market.
3 Jun 2014 | Price: $4515(SU) | View Details >>

The male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 4.9% during 2013-2020. Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. 20% of the total infertility is due to male factors. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing to the rise in male infertility levels. The major limitation experienced in the male infertility market is due to repeated treatment failures leading to an emotional impact on the patient.
29 Apr 2014 | Price: $4515(SU) | View Details >>

The advancement of IVF market in Asia Pacific is characterized by major factors such as the rising standards of living and growing number of couples delaying parenthood due to professional and financial commitments. The Asia Pacific IVF market, valued at $1.3 billion in 2012, is estimated to reach $4.2 billion by 2020. As the chances of conceiving lowers with age, delayed pregnancy in women is one of the major driving factors of the IVF market. The success rate of getting pregnant with IVF technique is higher within the age group of 35-39. Other driving factors of the IVF market are rise in infertility rates due to rise in stress levels, change in life style and fertility related diseases.
18 Mar 2014 | Price: $5315(SU) | View Details >>

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.
29 Jan 2014 | Price: $4515(SU) | View Details >>

Traditional wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal wounds, which take substantial time to heal and are expensive to treat. Advanced wound care & closure products are emerging as a standard solution for treating chronic wounds.
22 Jul 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

Particle size analysis is an analytical technique through which samples containing particulate material is distributed, measured and reported. This particulate material present could be in solid or liquid form. It is essential to analyze the particle’s size as it affects the material’s functioning. Increasing adoption of particle size analyzers in nanotechnology is contributing tothe growth of this market
Price: $4515 | Pre Book Price: $3950 | View Details >>

The safety of patientsand operators is a primary concern when it comes to medical power supply.Advances in technology and innovation are significantly impacting the medical power supply market.The growing demand for medical equipment which is smaller, more efficient, more cost-effective, reliable, and lighter is also affecting market growth.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Infusion pumps are medical devices that are used to deliver fluids, nutrients or medications (such as insulin and other hormones, chemotherapy drugs, antibiotics and pain relievers) into a patients body in a controlled manner. A number of infusion pumps are available for different applications.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Memory devices are the implantable devices designed to control the voluntary activities of brain or neuron in people who suffer from brain damage due to stroke, Alzheimers, and disruption of neural network due to chronic brain damage.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Vital signs, such as breathing rate, temperature, heartbeat and blood pressure are essential in measuring, monitoring and keeping a watch on basic body functioning. Vital signs devices thus play an important role in maintaining health as they monitor various vital parameters. The vital signs monitoring market comprises of services and devices for emergency care and support. The inclination of patients towards treatment at home as opposed to hospitals in order to cut costs is a significant trend witnessed in this market
Price: $4515 | Pre Book Price: $3950 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Request Quote



Pre Book Price
Original Price
$3950
$4515



WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top